How to buy AFT Pharmaceuticals (AFP) shares

AFT Pharmaceuticals Limited is a drug manufacturers-specialty & generic business based in Australia. AFT Pharmaceuticals shares (AFP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. AFT Pharmaceuticals has a trailing 12-month revenue of around $113.1 million. If you're looking to buy shares, check out the steps below.

How to buy shares in AFT Pharmaceuticals

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for AFT Pharmaceuticals. Find the share by name or ticker symbol: AFP. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AFT Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of AFT Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

US stocks

eToro (global stocks)

Finder Award

Our top pick for

Cheap broker fees

IG Share Trading

Finder Award

Our top pick for

Long-term investing

CMC Markets Stockbroking

Finder Award

AFT Pharmaceuticals stock price (ASX:AFP)

Compare share trading platforms

Sort by:

Name	Product	Standard brokerage fee	Inactivity fee	Markets
IG Share Trading Finder Award		AUD $8 or 0.1%	$50 per quarter if you make fewer than three trades in that period	ASX shares, Global shares	$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares. Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.	Go to site More Info	Compare	loading Fetching your data...
Superhero share trading		AUD $5	No	ASX shares, US shares, ETFs	Australia’s lowest-cost broker for ASX shares and ETFs. Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.	Go to site More Info	Compare	loading Fetching your data...
CMC Markets Stockbroking Finder Award		AUD $11 or 0.1%	No	ASX shares, Global shares, mFunds, ETFs	$0 brokerage on global shares including US, UK and Japan markets. Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.	Go to site More Info	Compare	loading Fetching your data...
Bell Direct Share Trading Finder AwardExclusive		AUD $15	No	ASX shares, mFunds, ETFs	⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct. Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.	Go to site More Info	Compare	loading Fetching your data...
Saxo Capital Markets (Classic account) Finder Award		AUD $6.99	No	ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs	Acess 19,000+ stocks on 37 exchanges worldwide Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.	Go to site More Info	Compare	loading Fetching your data...

loading

Prev

1

Next

Compare up to 4 providers

Clear selection

Compare

Is it a good time to buy AFT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is AFT Pharmaceuticals under- or over-valued?

Valuing AFT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AFT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AFT Pharmaceuticals's P/E ratio

AFT Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, AFT Pharmaceuticals shares trade at around 65x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

AFT Pharmaceuticals's EBITDA

AFT Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $11 million.

The EBITDA is a measure of a AFT Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

AFT Pharmaceuticals share dividends

We're not expecting AFT Pharmaceuticals to pay a dividend over the next 12 months.

AFT Pharmaceuticals share price volatility

Over the last 12 months, AFT Pharmaceuticals's shares have ranged in value from as little as $3.64 up to $5.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while AFT Pharmaceuticals's is 0.1714. This would suggest that AFT Pharmaceuticals's shares are less volatile than average (for this exchange).

AFT Pharmaceuticals overview

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals in the news

What Percentage Of AFT Pharmaceuticals Limited (NZSE:AFT) Shares Do Insiders Own?

Frequently asked questions

• What percentage of AFT Pharmaceuticals is owned by insiders or institutions?

  Currently 73.29% of AFT Pharmaceuticals shares are held by insiders and 6.356% by institutions.

• When does the fiscal year end for AFT Pharmaceuticals?

  AFT Pharmaceuticals's fiscal year ends in March.

• Where is AFT Pharmaceuticals based?

  AFT Pharmaceuticals's address is: 129 Hurstmere Road, Auckland, New Zealand, 0622

• What is AFT Pharmaceuticals's ISIN number?

  AFT Pharmaceuticals's international securities identification number is: NZAFTE0001S4